Company KPI Data Charting Tools Stock Screener Industry Financials Time Series Tables

Login Start for Free

My Subscriptions My Account My Orders Log Out

Research Tools

Company KPI Data
Charting Tools
Stock Screener
Industry Financials
Time Series Tables

Login Start for Free

Overview
Financial Statements
KPIs & Operating Metrics
Estimates
Peers
Ownership
- Institutional Ownership
- Insider Ownership
SEC Filings
Charts

Balance Sheet

Accounts Payables Accumulated Depreciation Accumulated Expenses Assets Capital Leases Cash & Equivalents Common Equity Construction in Progress Convertible Debt Current Assets Current Deferred Revenue Current Leases Current Taxes Liabilities and Shareholders Equity Long-Term Investments Non-Current Assets Non-Current Debt Non-Current Deffered Revenue Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Shares Preferred Stock Liabilities Prepaid Assets Property, Plant & Equipment (Net)Receivables Receivables - Accured Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares

Cash Flow Statement

Amortization of Deferred Charges Amortizatization of Intangibles Beginning Cash Balance Capital Expenditures Cash from Financing Activities Cash from Investing Activities Cash from Operations Change in Account Payables Change in Accured Expenses Change in Acquisitions & Divestments Change in Cash Change in Interest Receivables Change in Receivables Change in Taxes Depreciation & Amortization (CF)Exchange Rate Effect Free Cash Flow Gains from Investment Securities Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Income Non-cash Items Other financing activities Sales of Property, Plant and Equipment Share-based Compensation Shares Issued

Daily Values

DMA 100 DMA 200 DMA 50 Dividend Yield EV to CFO EV to EBIT EV to EBITDA EV to FCF EV to Revenue Market Cap to FCF Market Capitalization Price Price to Book Price to Earnings Price to Sales

Growth Metrics

EBIT Margin (QoQ)EBIT Margin Growth (1y)EBIT Margin Growth (3y)EBITDA Margin (QoQ)EBITDA Margin Growth (1y)EBITDA Margin Growth (3y)EBT Margin (QoQ)EBT Margin Growth (1y)EBT Margin Growth (3y)Enterprise Value (QoQ)Enterprise Value Growth (1y)Enterprise Value Growth (3y)FCF Margin (QoQ)FCF Margin Growth (1y)FCF Margin Growth (3y)Interest Coverage Ratio (QoQ)Interest Coverage Ratio Growth (1y)Interest Coverage Ratio Growth (3y)Net Margin (QoQ)Net Margin Growth (1y)Net Margin Growth (3y)Operating Margin (QoQ)Operating Margin Growth (1y)Operating Margin Growth (3y)Return on Assets (QoQ)Return on Assets Growth (1y)Return on Assets Growth (3y)Return on Capital Employed (QoQ)Return on Capital Employed Growth (1y)Return on Capital Employed Growth (3y)Return on Equity (QoQ)Return on Equity Growth (1y)Return on Equity Growth (3y)Return on Sales (QoQ)Return on Sales Growth (1y)Return on Sales Growth (3y)

Income Statement

Consolidated Net Income EBIT EBITDA EBT EPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing Operations Income towards Parent Company Interest & Investment Income Interest Expenses Net Income towards Common Stockholders Non Operating Income Operating Expenses Operating Income Other Non Operating Income Profit After Tax Research & Development Revenue Selling, General & Administrative Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions Tax Rate

Others

Accumulated Depreciation & Amortization Leases Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Property, Plant & Equipment (Gross)

Ratios

Asset Utilization Ratio Assets Average Debt Ratio Debt to Equity EBIT Margin EBITDA Margin EBT Margin Enterprise Value Equity Average Equity Ratio FCF Margin Interest Coverage Ratio Invested Capital Net Margin Operating Margin Return on Assets Return on Capital Employed Return on Equity Return on Sales Times Interest Earned

SAB Biotherapeutics (SABS) Current Taxes (2022)

Generated on {Timestamp} © BusinessQuant.com

Generated on {Timestamp} Powered by

Historic Current Taxes for SAB Biotherapeutics (SABS) over the last 1 years, with Q1 2022 value amounting to $92281.0.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value

×

Your powerful stock research platform

Resources

About Us
Sitemap
Contact Us

Company

Terms of Use
Privacy Policy
Plans & Pricing
Schedule a Demo

Create an account

Start your journey with us today. It's free!

I agree to the privacy policy.

Have an account already? Sign In

Sign In

Welcome back! Please enter your details.

Remember Me

Forgot Password?

Don't have an account? Create one now

Reset Password

Enter your email to receive a reset link.

Back to Sign In

Get Pro for 60% off

Access all features immediately
Segment financials and operating data
Export data in CSV and XLSX formats

Offer Ends In

00Days

00Hours

00Minutes

00Seconds

Starting from ~~$49~~ $19 / month

Claim Discount